Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
Data also show that several other leading domestic pharma companies have recalled their products from the US
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances